With all the different language and statements regarding licensing or going it alone, it appears CYDY may be at a critical decision point. Maybe the offers aren’t good enough based on CYDY revenue predictions? If they’re considering going it alone, they must believe they can make it to market with dilutive financing or at least an up front cash payment for the prostate test. He did mention in the video that the licensing for the prostate test is ongoing, so that’s good.